# Filing Detail

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001104659-24-008168
Filing Date
2024-01-30
Accepted
2024-01-30 15:16:56
Documents
63

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM F-1/A | tm2334005-3_f1a.htm | F-1/A | 5705486
2 | EXHIBIT 4.4 | tm2334005d4_ex4-4.htm | EX-4.4 | 110668
3 | EXHIBIT 4.5 | tm2334005d4_ex4-5.htm | EX-4.5 | 110451
4 | EXHIBIT 4.6 | tm2334005d4_ex4-6.htm | EX-4.6 | 113031
5 | EXHIBIT 5.1 | tm2334005d4_ex5-1.htm | EX-5.1 | 35803
6 | EXHIBIT 8.2 | tm2334005d4_ex8-2.htm | EX-8.2 | 19722
7 | EXHIBIT 10.1 | tm2334005d4_ex10-1.htm | EX-10.1 | 233402
8 | EXHIBIT 23.1 | tm2334005d4_ex23-1.htm | EX-23.1 | 2649
9 | EX-FILING FEES | tm2334005d4_ex-filingfees.htm | EX-FILING FEES | 60025
10 | GRAPHIC | bc_fig13pioneer-4c.jpg | GRAPHIC | 30201
11 | GRAPHIC | bc_fig16stage-4c.jpg | GRAPHIC | 30594
12 | GRAPHIC | bc_fig19lesions-4c.jpg | GRAPHIC | 41911
13 | GRAPHIC | bc_fig43kidneys-4c.jpg | GRAPHIC | 25167
14 | GRAPHIC | bc_fig47immunization-4c.jpg | GRAPHIC | 26783
15 | GRAPHIC | bc_fig48splenocytes-4c.jpg | GRAPHIC | 35423
16 | GRAPHIC | bc_fig49akilling-4c.jpg | GRAPHIC | 76748
17 | GRAPHIC | bc_fig49killing-4c.jpg | GRAPHIC | 38699
18 | GRAPHIC | bc_fig51tcellresponse-4c.jpg | GRAPHIC | 43939
19 | GRAPHIC | bc_fig52antibody-4c.jpg | GRAPHIC | 22079
20 | GRAPHIC | fc_fig03aiimmunolonew-4clr.jpg | GRAPHIC | 99521
21 | GRAPHIC | fc_fig05stagedevelop-4c.jpg | GRAPHIC | 45718
22 | GRAPHIC | fc_fig06ourstarat-4c.jpg | GRAPHIC | 112297
23 | GRAPHIC | fc_fig12cancer-4c.jpg | GRAPHIC | 43857
24 | GRAPHIC | fc_fig15pioneer-4c.jpg | GRAPHIC | 42345
25 | GRAPHIC | fc_fig17vaccine-4clr.jpg | GRAPHIC | 82873
26 | GRAPHIC | fc_fig24pembrolizumab-4c.jpg | GRAPHIC | 21785
27 | GRAPHIC | fc_fig36discovery-4c.jpg | GRAPHIC | 127689
28 | GRAPHIC | fc_fig38eden-4clr.jpg | GRAPHIC | 115130
29 | GRAPHIC | fc_fig39vaccine-4c.jpg | GRAPHIC | 56940
30 | GRAPHIC | fc_fig44glase-4c.jpg | GRAPHIC | 119623
31 | GRAPHIC | fc_fig50panproteome-4c.jpg | GRAPHIC | 82816
32 | GRAPHIC | lc_fig14tumorvolum-4c.jpg | GRAPHIC | 78226
33 | GRAPHIC | lc_fig20prepost-bw.jpg | GRAPHIC | 55776
34 | GRAPHIC | lc_fig21prepostfollow-bw.jpg | GRAPHIC | 44542
35 | GRAPHIC | lc_fig22mannwhitney-bw.jpg | GRAPHIC | 42349
36 | GRAPHIC | lc_fig23neoantigen-4c.jpg | GRAPHIC | 70709
37 | GRAPHIC | lc_fig27tumor-4c.jpg | GRAPHIC | 38500
38 | GRAPHIC | lc_fig28isotype-4c.jpg | GRAPHIC | 52750
39 | GRAPHIC | lc_fig29control-4c.jpg | GRAPHIC | 75360
40 | GRAPHIC | lc_fig30inoculation-4c.jpg | GRAPHIC | 69578
41 | GRAPHIC | lc_fig31backbone-4c.jpg | GRAPHIC | 49275
42 | GRAPHIC | lc_fig33clinical-bw.jpg | GRAPHIC | 96970
43 | GRAPHIC | lc_fig34liuhugovan-4c.jpg | GRAPHIC | 53554
44 | GRAPHIC | lc_fig37neisseria-bw.jpg | GRAPHIC | 142520
45 | GRAPHIC | lc_fig40evxb1-4c.jpg | GRAPHIC | 23812
46 | GRAPHIC | lc_fig41abcess-4c.jpg | GRAPHIC | 37370
47 | GRAPHIC | lc_fig42halfmax-4c.jpg | GRAPHIC | 21351
48 | GRAPHIC | lc_fig45evxb2-4c.jpg | GRAPHIC | 98294
49 | GRAPHIC | lc_fig46auclog-4c.jpg | GRAPHIC | 63204
50 | GRAPHIC | lg_evaxionaiimmunology-bwlr.jpg | GRAPHIC | 10969
51 | GRAPHIC | pc_fig04aiimmunolo-4c.jpg | GRAPHIC | 57315
52 | GRAPHIC | ph_fig25week-4c.jpg | GRAPHIC | 117538
53 | GRAPHIC | ph_fig26evx2evx3-4clr.jpg | GRAPHIC | 78952
54 | GRAPHIC | ph_fig35bacterial-4c.jpg | GRAPHIC | 56165
55 | GRAPHIC | tb_fig02milestones-4c.jpg | GRAPHIC | 67060
56 | GRAPHIC | tb_fig18tumor-4c.jpg | GRAPHIC | 76653
57 | GRAPHIC | tb_fig20trae-4clr.jpg | GRAPHIC | 21615
58 | GRAPHIC | tb_fig32inoculatnew-4clr.jpg | GRAPHIC | 45681
59 | GRAPHIC | tm233400d4_ex8-2img001.jpg | GRAPHIC | 2848
60 | GRAPHIC | tm233400d4_ex8-2img002.jpg | GRAPHIC | 1737
61 | GRAPHIC | tm2334005d4_ex5-1img001.jpg | GRAPHIC | 3160
62 | GRAPHIC | tm2334005d4_ex5-1img002.jpg | GRAPHIC | 798
63 | GRAPHIC | tm2334005d4_ex5-1img003.jpg | GRAPHIC | 1887
| Complete submission text file | 0001104659-24-008168.txt |  | 10406715

Mailing Address DR NEERGAARDS VEJ 5F HOERSHOLM G7 2970
Business Address DR NEERGAARDS VEJ 5F HOERSHOLM G7 2970 004531262615
Evaxion Biotech A/S (Filer) CIK: 0001828253 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-276505 | Film No.: 24577750
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)